Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Medtronic (MDT) -- Ignore unavailable to you. Want to Upgrade?

To: macaluso who wrote (303)	6/25/1998 7:51:00 AM
From: Dennis	Respond to of 687

Maybe this has something to do with the pop UP: (Found this on the AVEI thread) Market For Cardiac Devices Set to Increase to $11.8 Billion By 2001, Says Clinica's Latest Cardiovascular Report RICHMOND, UK, June 22 /PRNewswire/ -- The CVD market is still proving to be an attractive market for new entrants. Developments in less invasive surgery techniques and devices, plus a global increase in the occurrence of cardiovascular disease have led to a sustained interest in the market for new products. Cardiovascular disease is the predominant cause of premature death in the developed countries of the world. The populations of developed nations are aging and emerging nations are embracing Western lifestyles that will eventually lead to a massive increase in CVD in these countries -- many of these nations already have large, wealthy middle classes readily able to afford high quality medical care. Recent treatments for cardiovascular disease are examined in a new title from Clinica Reports. ''Clinica's Complete Guide to Cardiovascular Devices'' includes the cardiovascular devices that are employed for the treatment of CVDs are numerous and varied and the report focuses on those most commonly used, i.e. PTCA systems, vascular stents, atherectomy devices, implantable pacemakers, implantable defibrillators, cardiac ablation catheters, prosthetic heart valves, vascular grafts, cardiovascular repair fabrics and PTA systems. Key participants in this market that are profiled in this report are: Ave Inc., CR Bard, Baxter International, Boston Scientific Corp [NYSE:BSX - news], Guidant, Johnson & Johnson,Medtronic, Schneider, St. Jude Medical, Sulzer Medica, Ventritex. Profiles include an informative company overview, details of financial performance and sales of devices by geographic area, product descriptions and details of R&D activity. Clinica's Complete Guide to Cardiovascular Devices Price: pounds sterling 495 / US$1,040. As an investor you have got to love the demographics, as a person this is terrible BUT I agree. The physical condition of we boomers and YOUNGER is awful .